Karakterisasi Densitas Grafit Sebagai Kandidat Bahan Reaktor Temperatur Tinggi

-Characterization on graphite density has been done. The characterizations were done by analyzed X-ray diffraction pattern using Rietveld method compared to the density measurement according to ASTM C373 and ASTM C559. Microstructure observation by optical microscope was done to prove the density characteristic of graphite electrode. The results showed the graphite electrode was 2H graphite allotrope with hexagonal crystal system and its space group is P 63 m c. Rietveld analysis for lattice parameter was achieved at a=2,4627 Å and c=6,7215 Å, with density at 2,26 g/cm3. Density measurement based on ASTM C373 at 2,41 g/cm3, and based on ASTM C559 at 2,28 g/cm3. The observation microstructure appearance showed high density in graphite. The density measurement showed the graphite electrode has passed one criteria to be used in high temperature reactor

Cost Effectiveness of Human Papillomavirus Vaccination for Men Who have Sex with Men; Reviewing the Available Evidence

BACKGROUND: Men who have sex with men require special attention for human papillomavirus vaccination given elevated infection risks and the development of, in particular, anal cancer. OBJECTIVE: Our purpose was to review the cost effectiveness of human papillomavirus vaccination for both currently vaccine-eligible and non-eligible individuals, particularly the men-who-have-sex-with-men population, and synthesize the available evidence. METHODS: We systematically searched for published articles in two main databases (PubMed and EMBASE). Screening and data extraction were performed by two independent reviewers. The risk of bias was assessed using a validated instrument (Bias in Economic Evaluation, ECOBIAS). Methodological aspects, study results, and sensitivity analyses were extracted and synthesized to generate a consistent overview of the cost effectiveness of human papillomavirus vaccination in the men-who-have-sex-with-men population. RESULTS: From 770 identified articles, four met the inclusion criteria. Across the studies, human papillomavirus vaccination showed incremental cost-effectiveness ratios ranging from dominant to US$96,146 and US$14,000 to US$18,200 for tertiary prevention and primary prevention, respectively. The incremental cost-effectiveness ratio seemed most sensitive to vaccine efficacy, vaccine costs, and the incidence of anal cancer in the selected target populations. CONCLUSION: This review presents the human papillomavirus vaccine, both as a primary and adjuvant (tertiary) vaccination, as a potentially cost-effective strategy for preventing mainly-but not limited to only-anal cancer in men-who-have-sex-with-men populations

Penentuan Koduktivitas Panas Komposit Matriks Keramik Silikon Karbida Menggunakan Differential Scanning Calorimetry

- Thermal conductivity of silicon carbide composite matrix ceramic (CMC) was determined by differential scanning calorimetry (DSC) using Setaram DSC 92. Thermal conductivity measurement conducted by DSC was determined by enthalpi curve of sensor material was used Indium with melting point at 156,6 o C which thermal resistance of CMC SiC calculated. Thickness of CMC SiC and area of sensor material that contact to the CMC SiC sample. Thermal resistance of CMC SiC that obtained from enthalpi curve for KMK-P at 0,897 K/mW and KMK-PS at 0,867 K/mW. Thermal conductivity value that calculater from obtained thermal resistance for KMK-P at 2,919 W/m.K and KMK-PS at 3,065 W/m.K

Studi Kekuatan Tarik Serat Nonwoven Silikon Karbida

-Tensile strength measurement has been done for silicon carbide nonwoven fiber that produced for polycarbosilane using electrospinning technique. Silicon carbide nonwoven fibers produced with the same process parameter (high voltage, tip to collector distance and feed rate solution). The curing process time varied at 1, 1.5 and 2 hour(s). The pyrolysis process took placed after the curing process for 1 hour. Tensile measurement for the nonwoven fiber has done by framed the sample and the pulling speed at 1 mm/s. The results showed the tensile strength of nonwoven fiber has a lower value compared to the woven silicon carbide fiber. Tensile strength of the fibers against the curing process time were 1.85 MPa, 8.98 MPa and 10.66 MPa, respectively. The fibers diameter value against the curing process time were 6.13, 4.17 and 4.23 μm. These results showed the fibers toughness take the tensile load caused by the friction and adhesion inter-fibers, then the elasticity of fibers depend on the fibers diameter

Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries:a meta-analysis

Cervical cancer is a serious public-health problem in Asian countries. Since human papillomavirus (HPV) infection is the main risk factor for cervical cancer, HPV vaccination is considered a promising strategy to prevent cervical cancer. However, comprehensive immunogenicity and safety information for Asian populations is lacking. We searched four electronic databases including PubMed, EMBASE, Cochrane Library, and clinicaltrials.gov. We reviewed selected manuscripts and extracted the pooled relative risk (RR) from immunogenicity and safety information on HPV vaccination among women in Asian countries. We identified two quadrivalentvaccine studies and eight bivalent-vaccine studies conducted in Asian countries. Analysis across these studies suggested that the HPV vaccines significantly enhanced HPV16- and HPV18-specific antibody among both uninfected (RR 85.69; 95% confidence interval (CI) 31.51-233.04 and 62.77; 95% CI 37.4-105.51) and infected individuals (RR 8.60; 95% CI 6.95-10.64 and RR 8.13; 95% CI 5.96-11.11). Furthermore, HPV vaccination among Asian populations has a favorable safety profile, with only slightly higher risks of local (RR: 1.89; 95% CI 1.65-2.17) and systemic (RR: 1.33; 95% CI 1.18-1.50) adverse events in vaccinated individuals compared with controls. For Asian populations, HPV vaccines enhance the level of HPV16- and HPV18-specific antibodies for both uninfected and infected individuals. Also, the risk of adverse events related to vaccination are acceptable. More data are needed to establish vaccine efficacy with regard to prevention of HPV infection and further outcomes including cervical intraepithelial neoplasia (CIN) and cervical cancer

Prevention of Surgical Site Infections:A Systematic Review of Cost Analyses in the Use of Prophylactic Antibiotics

Introduction: The preoperative phase is an important period in which to prevent surgical site infections (SSIs). Prophylactic antibiotic use helps to reduce SSI rates, leading to reductions in hospitalization time and cost. In clinical practice, besides effectiveness and safety, the selection of prophylactic antibiotic agents should also consider the evidence with regard to costs and microbiological results. This review assessed the current research related to the use of antibiotics for SSI prophylaxis from an economic perspective and the underlying epidemiology of microbiological findings. Methods: A literature search was carried out through PubMed and Embase databases from 1 January 2006 to 31 August 2017. The relevant studies which reported the use of prophylactic antibiotics, SSI rates, and costs were included for analysis. The causing pathogens for SSIs were categorized by sites of the surgery. The quality of reporting on each included study was assessed with the "Consensus on Health Economic Criteria" (CHEC). Results: We identified 20 eligible full-text studies that met our inclusion criteria, which were subsequently assessed, studies had in a reporting quality scored on the CHEC list averaging 13.03 (8-18.5). Of the included studies, 14 were trial-based studies, and the others were model-based studies. The SSI rates ranged from 0 to 71.1% with costs amounting to US$480-22,130. Twenty-four bacteria were identified as causative agents of SSIs. Gram negatives were the dominant causes of SSIs especially in general surgery, neurosurgery, cardiothoracic surgery, and obstetric cesarean sections. Conclusions: Varying results were reported in the studies reviewed. Yet, information from both trial-based and model-based costing studies could be considered in the clinical implementation of proper and efficient use of prophylactic antibiotics to prevent SSIs and antimicrobial resistance

Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavenging

The human cytomegalovirus (HCMV)-encoded chemokine receptor US28 contributes to various aspects of the viral life cycle and promotes immune evasion by scavenging chemokines from the microenvironment of HCMV-infected cells. In contrast to the plasma membrane localization of most human chemokine receptors, US28 has a predominant intracellular localization. In this study, we used immunofluorescence and electron microscopy to determine the localization of US28 upon exogenous expression, as well as in HCMV-infected cells. We observed that US28 localizes to late endosomal compartments called multivesicular bodies (MVBs), where it is sorted in intraluminal vesicles. Live-cell total internal reflection fluorescence (TIRF) microscopy revealed that US28-containing MVBs can fuse with the plasma membrane, resulting in the secretion of US28 on exosomes. Exosomal US28 binds the chemokines CX 3CL1 and CCL5, and US28-containing exosomes inhibited the CX 3CL1-CX 3CR1 signaling axis. These findings suggest that exosomal release of US28 contributes to chemokine scavenging and immune evasion by HCMV

Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci

BACKGROUND: Known risk alleles for epithelial ovarian cancer (EOC) account for approximately 40% of the heritability for EOC. Copy number variants (CNVs) have not been investigated as EOC risk alleles in a large population cohort. METHODS: Single nucleotide polymorphism array data from 13 071 EOC cases and 17 306 controls of White European ancestry were used to identify CNVs associated with EOC risk using a rare admixture maximum likelihood test for gene burden and a by-probe ratio test. We performed enrichment analysis of CNVs at known EOC risk loci and functional biofeatures in ovarian cancer-related cell types. RESULTS: We identified statistically significant risk associations with CNVs at known EOC risk genes; BRCA1 (PEOC = 1.60E-21; OREOC = 8.24), RAD51C (Phigh-grade serous ovarian cancer [HGSOC] = 5.5E-4; odds ratio [OR]HGSOC = 5.74 del), and BRCA2 (PHGSOC = 7.0E-4; ORHGSOC = 3.31 deletion). Four suggestive associations (P < .001) were identified for rare CNVs. Risk-associated CNVs were enriched (P < .05) at known EOC risk loci identified by genome-wide association study. Noncoding CNVs were enriched in active promoters and insulators in EOC-related cell types. CONCLUSIONS: CNVs in BRCA1 have been previously reported in smaller studies, but their observed frequency in this large population-based cohort, along with the CNVs observed at BRCA2 and RAD51C gene loci in EOC cases, suggests that these CNVs are potentially pathogenic and may contribute to the spectrum of disease-causing mutations in these genes. CNVs are likely to occur in a wider set of susceptibility regions, with potential implications for clinical genetic testing and disease prevention